The uninvited guests of our microbiome: Helicobacter pylori and Epstein-Barr virus and their role in gastric cancerogenesis

[1]NIH Human Microbiome Project http://www.hmpdacc.org (03.06.2020) NIH Human Microbiome Project http://www.hmpdacc.org (03.06.2020)Search in Google Scholar

[2]Sender R., Fuchs S., Milo R.: Revised estimates for the number of human and bacteria cells in the body. PLoS Biol., 2016; 14: e1002533 Sender R. Fuchs S. Milo R. Revised estimates for the number of human and bacteria cells in the body PLoS Biol 2016 14 e100253310.1371/journal.pbio.1002533499189927541692Search in Google Scholar

[3]Rowan-Nash A.D., Korry B.J., Mylonakis E., Belenky P.: Cross-domain and viral interactions in the microbiome. Microbiol. Mol. Biol. Rev., 2019; 83: e00044-18 Rowan-Nash A.D. Korry B.J. Mylonakis E. Belenky P. Cross-domain and viral interactions in the microbiome Microbiol. Mol. Biol. Rev 2019 83 e00044 1810.1128/MMBR.00044-18638344430626617Search in Google Scholar

[4]Warren J.R., Marshall B.: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet, 1983; 1: 1273-1275 Warren J.R. Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis Lancet 1983 1 1273 127510.1016/S0140-6736(83)92719-8Search in Google Scholar

[5]Hallen-Adams H.E., Suhr M.J.: Fungi in the healthy human gastrointestinal tract. Virulence, 2017; 8: 352-358 Hallen-Adams H.E. Suhr M.J. Fungi in the healthy human gastrointestinal tract Virulence 2017 8 352 35810.1080/21505594.2016.1247140541123627736307Search in Google Scholar

[6]Huseyin C.E., O’Toole P.W., Cotter P.D., Scanlan P.D.: Fortotten fungi – the gut mycobiome in human health and disease. FEMS Microbiol. Rev., 2017; 41: 479- 511 Huseyin C.E. O’Toole P.W. Cotter P.D. Scanlan P.D. Fortotten fungi – the gut mycobiome in human health and disease FEMS Microbiol. Rev 2017 41 479–51110.1093/femsre/fuw04728430946Search in Google Scholar

[7]Massarrat S., Saniee P., Siavoshi F., Mkhtari R., Mansour-Ghanaei F., Khalili-Samani S.: The effect of Helicobacter pylori infection, aging and consumption of proton pump inhibitor on fungal colonization in the stomach of dyspeptic patients. Front. Microbiol., 2016; 7: 801 Massarrat S. Saniee P. Siavoshi F. Mkhtari R. Mansour-Ghanaei F. Khalili-Samani S. The effect of Helicobacter pylori infection, aging and consumption of proton pump inhibitor on fungal colonization in the stomach of dyspeptic patients Front. Microbiol 2016 7 80110.3389/fmicb.2016.00801487913327252698Search in Google Scholar

[8]Wang Z.K., Yang Y.S., Stefka A.T., Sun G., Peng L.H.: Review article: Fungal microbiota and digestive diseases. Aliment. Pharmacol. Ther., 2014; 39: 751-766 Wang Z.K. Yang Y.S. Stefka A.T. Sun G. Peng L.H. Review article: Fungal microbiota and digestive diseases Aliment. Pharmacol. Ther 2014 39 751 76610.1111/apt.1266524612332Search in Google Scholar

[9]Khosravi Y., Gan H.M., Chia P.J., Croft L.J., Ng C.G., Goh K.L., Vellasamy K.M., Mariappan V., Ong K.C., Wong K.T., et al.: The gastric microbiome of four Malaysian gastroduodenal disease patients. Arch. Gene Genome Res., 2017; 1: 1-9 Khosravi Y. Gan H.M. Chia P.J. Croft L.J. Ng C.G. Goh K.L. Vellasamy K.M. Mariappan V. Ong K.C. Wong K.T. et al The gastric microbiome of four Malaysian gastroduodenal disease patients Arch. Gene Genome Res 2017 1 1 910.36959/998/781Search in Google Scholar

[10]Wołkowicz T., Januszkiewicz A., Szych J.: Gut microbiome and its dysbiosis as an important factor influencing the human health condition. Med. Dośw. Mikrobiol., 2014; 66: 223-235 Wołkowicz T. Januszkiewicz A. Szych J. Gut microbiome and its dysbiosis as an important factor influencing the human health condition Med. Dośw. Mikrobiol 2014 66 223 235Search in Google Scholar

[11]Huffnagle G.B., Noverr M.C.: The emerging world of the fungal microbiome. Trends Microbiol., 2013; 21: 334-341 Huffnagle G.B. Noverr M.C. The emerging world of the fungal microbiome Trends Microbiol 2013 21 334 34110.1016/j.tim.2013.04.002370848423685069Search in Google Scholar

[12]Karczewska E., Wojtas I., Trojanowska D., Budak A., Zwolinska-Wcisło M., Wilk A.: Assessment of co-existence of Helicobacter pylori and Candida fungi in diseases of the upper gastrointestinal tract. J. Physiol. Pharmacol., 2009; 60: 33-39 Karczewska E. Wojtas I. Trojanowska D. Budak A. Zwolinska-Wcisło M. Wilk A. Assessment of co-existence of Helicobacter pylori and Candida fungi in diseases of the upper gastrointestinal tract J. Physiol. Pharmacol 2009 60 33 39Search in Google Scholar

[13]Lincoñir-Campos P., Merino-Barrera J.S., Smith C.T., Garcia-Cancino A.: Candida sp. as a potential reservoir and transmission facilitator of Helicobacter pylori. Biomed. J. Sci. & Tech. Res., 2018; 4: 3736-3738 Lincoñir-Campos P. Merino-Barrera J.S. Smith C.T. Garcia-Cancino A. Candida sp as a potential reservoir and transmission facilitator of Helicobacter pylori. Biomed. J. Sci. & Tech. Res 2018 4 3736 373810.26717/BJSTR.2018.04.0001002Search in Google Scholar

[14]Fol M., Jachowicz E.: Czynniki zakaźne w procesie nowotworzenia. Med. Og. Nauk. Zdr., 2016; 22: 7-14 Fol M. Jachowicz E. Czynniki zakaźne w procesie nowotworzenia Med. Og. Nauk. Zdr 2016 22 7 1410.5604/20834543.1198717Search in Google Scholar

[15]Armstrong H., Bording-Jorgensen M., Dijk S., Wine E.: The complex interplay between chronic inflammation, the microbiome and cancer: Understanding disease progression and what we can do to prevent it. Cancers, 2018; 10: 83 Armstrong H. Bording-Jorgensen M. Dijk S. Wine E. The complex interplay between chronic inflammation, the microbiome and cancer: Understanding disease progression and what we can do to prevent it Cancers 2018 10 8310.3390/cancers10030083587665829558443Search in Google Scholar

[16]Abbas M.K., Zaidi A.R.Z., Robert C.A., Thiha S., Malik B.H.: The safety of long-term daily usage of a proton pump inhibitor: A literature review. Cereus, 2019; 11: e5563 Abbas M.K. Zaidi A.R.Z. Robert C.A. Thiha S. Malik B.H. The safety of long-term daily usage of a proton pump inhibitor: A literature review Cereus 2019 11 e556310.7759/cureus.5563672877631523592Search in Google Scholar

[17]Jump R.L.: Clostridium difficile infection in older adults. Aging Health, 2013; 9: 403-414 Jump R.L. Clostridium difficile infection in older adults Aging Health 2013 9 403 41410.2217/ahe.13.37406170524955106Search in Google Scholar

[18]Cheung K.S., Leung W.K.: Risk of gastric cancer development after eradication of Helicobacter pylori. World J. Gastrointest. Oncol., 2018; 10: 115-123 Cheung K.S. Leung W.K. Risk of gastric cancer development after eradication of Helicobacter pylori World J. Gastrointest. Oncol 2018 10 115 12310.4251/wjgo.v10.i5.115595226829770171Search in Google Scholar

[19]Joo M.K., Park J.J., Chun H.J.: Proton pump inhibitor: The dual role in gastric cancer. World J. Gastroenterol., 2019; 25: 20582070. Joo M.K. Park J.J. Chun H.J. Proton pump inhibitor: The dual role in gastric cancer World J. Gastroenterol 2019 25 2058207010.3748/wjg.v25.i17.2058650657631114133Search in Google Scholar

[20]Global Burden of Disease Cancer Collaboration, Fitzmaurice C., Allen C., Barber R.M., Barregard L., Bhutta Z.A., Brenner H., Dicker D.J., Chimed-Orchir O., Dandona R., et al.: Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncol., 2017; 3: 524-548 Global Burden of Disease Cancer Collaboration Fitzmaurice C. Allen C. Barber R.M. Barregard L. Bhutta Z.A. Brenner H. Dicker D.J. Chimed-Orchir O. Dandona R. et al Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study JAMA Oncol 2017 3 524 54810.1001/jamaoncol.2016.5688610352727918777Search in Google Scholar

[21]Gunathilake M.N., Lee J., Choi I.J., Kim Y.I., Ahn Y., Park C., Kim J.: Association between the relative abundance of gastric micro-biota and the risk of gastric cancer: A case control study. Sci. Rep., 2019; 9: 13589 Gunathilake M.N. Lee J. Choi I.J. Kim Y.I. Ahn Y. Park C. Kim J. Association between the relative abundance of gastric micro-biota and the risk of gastric cancer: A case control study Sci. Rep 2019 9 1358910.1038/s41598-019-50054-x675319431537876Search in Google Scholar

[22]National Cancer Institute, Surveillance Epidemiology, and End Results Program, https://seer.cancer.gov/statfacts/html/stomach. html (15.06.2020) National Cancer Institute, Surveillance Epidemiology, and End Results Program https://seer.cancer.gov/statfacts/html/stomach. html (15.06.2020)Search in Google Scholar

[23]The Cancer Genome Atlas Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature, 2014; 513: 202-209 The Cancer Genome Atlas Research Network Comprehensive molecular characterization of gastric adenocarcinoma Nature 2014 513 202 20910.1038/nature13480417021925079317Search in Google Scholar

[24]Seekatz A.M., Schinzlein M.K., Koenigsknecht M.J., Baker J.R., Hasler W.L., Bleske B.E., Young V.B., Sun D.: Spatial and temporal analysis of the stomach and smallintestinal microbiota in fasted healthy humans. mSphere, 2019; 4: e00126-19 Seekatz A.M. Schinzlein M.K. Koenigsknecht M.J. Baker J.R. Hasler W.L. Bleske B.E. Young V.B. Sun D. Spatial and temporal analysis of the stomach and smallintestinal microbiota in fasted healthy humans mSphere 2019 4 e00126 1910.1128/mSphere.00126-19641636630867328Search in Google Scholar

[25]Nardone G., Compare D.: The human gastric microbiota: Is it time to rethink the pathogenesis of stomach diseases? United European Gastroenterol. J., 2015; 3: 255-260 Nardone G. Compare D. The human gastric microbiota: Is it time to rethink the pathogenesis of stomach diseases? United European Gastroenterol. J 2015 3 255 26010.1177/2050640614566846448053526137299Search in Google Scholar

[26]Sheh A., Fox J.G.: The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes, 2013; 4: 505-531 Sheh A. Fox J.G. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis Gut Microbes 2013 4 505 53110.4161/gmic.26205392816223962822Search in Google Scholar

[27]Bassis C.M., Erb-Downward J.R., Dickson R.P., Freeman C.M., Schmidt T.M., Young V.B., Beck J.M., Curtis J.L., Huffnagle G.B.: Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. mBio, 2015; 6: e00037 Bassis C.M. Erb-Downward J.R. Dickson R.P. Freeman C.M. Schmidt T.M. Young V.B. Beck J.M. Curtis J.L. Huffnagle G.B. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals mBio 2015 6 e0003710.1128/mBio.00037-15435801725736890Search in Google Scholar

[28]Malinowska M., Tokarz-Deptuła B., Deptuła W.: Mikrobiom człowieka. Post. Mikrobiol., 2017; 56: 33-42 Malinowska M. Tokarz-Deptuła B. Deptuła W. Mikrobiom człowieka Post. Mikrobiol 2017 56 33 4210.5114/ceji.2017.72806Search in Google Scholar

[29]Rośniak-Bąk K., Pawłowska A., Paradowski M.: Helicobcter pylori: Cechy biochemiczne i patogenne bakterii oraz metody rozpoznawania zakażeń. Diagn. Lab., 2008; 44: 371-378 Rośniak-Bąk K. Pawłowska A. Paradowski M. Helicobcter pylori: Cechy biochemiczne i patogenne bakterii oraz metody rozpoznawania zakażeń Diagn. Lab 2008 44 371 378Search in Google Scholar

[30]Swora E., Stankowiak-Kulpa H., Marcinkowska E., Grzymisławski M.: Kliniczne aspekty diagnostyki zakażenia Helicobacter pylori. Now. Lek., 2009; 78: 228-230 Swora E. Stankowiak-Kulpa H. Marcinkowska E. Grzymisławski M. Kliniczne aspekty diagnostyki zakażenia Helicobacter pylori Now. Lek 2009 78 228 230Search in Google Scholar

[31]Minalyan A., Gabrielyan L., Scott D., Jacobs J., Pisegna J.R.: The gastric and intestinal microbiome: Role of proton pump inhibitors. Curr. Gastroenterol. Rep., 2017; 19: 42 Minalyan A. Gabrielyan L. Scott D. Jacobs J. Pisegna J.R. The gastric and intestinal microbiome: Role of proton pump inhibitors Curr. Gastroenterol. Rep 2017 19 4210.1007/s11894-017-0577-6562151428733944Search in Google Scholar

[32]Brawner K.M., Kumar R., Serrano C.A., Ptacek T., Lefkowitz E., Morrow C.D., Zhi D., Kyanam-Kabir-Baig K.R., Smythies L.E., Harris P.R., Smith P.D.: Helicobacter pylori infection is associated with an altered gastric microbiota in children. Mucosal Immunol., 2017; 10: 1169-1177 Brawner K.M. Kumar R. Serrano C.A. Ptacek T. Lefkowitz E. Morrow C.D. Zhi D. Kyanam-Kabir-Baig K.R. Smythies L.E. Harris P.R. Smith P.D. Helicobacter pylori infection is associated with an altered gastric microbiota in children Mucosal Immunol 2017 10 1169 117710.1038/mi.2016.131552674628120843Search in Google Scholar

[33]Noto J.M., Peek R.M.Jr.: The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to stomach cancer. PLoS Pathog., 2017; 13: e1006573 Noto J.M. Peek R.M.Jr. The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to stomach cancer PLoS Pathog 2017 13 e100657310.1371/journal.ppat.1006573562902728982167Search in Google Scholar

[34]Ermolenko E., Varsin S., Baryshnikova N., Svarval A., Ferman R., Besedina N., Zakrevskaya A., Molostova A., Suvorov A.: Gastrointestinal dysbiosis accompanied of Helicobacter pylori infection and its correction by probiotic. J. Clin. Gastroenterol. Treat., 2018; 4: 055 Ermolenko E. Varsin S. Baryshnikova N. Svarval A. Ferman R. Besedina N. Zakrevskaya A. Molostova A. Suvorov A. Gastrointestinal dysbiosis accompanied of Helicobacter pylori infection and its correction by probiotic J. Clin. Gastroenterol. Treat 2018 4 05510.23937/2469-584X/1510055Search in Google Scholar

[35]Eun C.S., Kim B.K., Han D.S., Kim S.Y., Kim K.M., Choi B.Y., Song K.S., Kim Y.S., Kim J.F.: Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal meta-plasia, and gastric cancer using pyrosequencing methods. Helicobacter, 2014; 19: 407-416 Eun C.S. Kim B.K. Han D.S. Kim S.Y. Kim K.M. Choi B.Y. Song K.S. Kim Y.S. Kim J.F. Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal meta-plasia, and gastric cancer using pyrosequencing methods Helicobacter 2014 19 407 41610.1111/hel.1214525052961Search in Google Scholar

[36]Aviles-Jiminez F., Vazquez-Jiminez F., Medrano-Guzman R., Mantilla A., Torres J.: Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci. Rep., 2014; 4: 4202 Aviles-Jiminez F. Vazquez-Jiminez F. Medrano-Guzman R. Mantilla A. Torres J. Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer Sci. Rep 2014 4 420210.1038/srep04202393518724569566Search in Google Scholar

[37]Hu Y.L., Pang W., Huang Y., Zhang Y., Zhang C.J.: The gastric microbiome is perturbed in advanced gastric adenocarcinoma identified through shotgun metagenomics. Front. Cell. Infect. Microbiol., 2018; 8: 433 Hu Y.L. Pang W. Huang Y. Zhang Y. Zhang C.J. The gastric microbiome is perturbed in advanced gastric adenocarcinoma identified through shotgun metagenomics Front. Cell. Infect. Microbiol 2018 8 43310.3389/fcimb.2018.00433629987430619779Search in Google Scholar

[38]Ferreira R.M., Pereira-Marques J., Pinto-Ribeiro I., Costa J.L., Carneiro F., Machado J.C., Figueiredo C.: Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut, 2018; 67: 226-236 Ferreira R.M. Pereira-Marques J. Pinto-Ribeiro I. Costa J.L. Carneiro F. Machado J.C. Figueiredo C. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota Gut 2018 67 226 23610.1136/gutjnl-2017-314205586829329102920Search in Google Scholar

[39]Castaño-Rodríguez N., Goh K.L., Fock K.M., Mitchell H.M., Kaakoush N.O.: Dysbiosis of the microbiome in gastric carcinogenesis. Sci. Rep., 2017; 7: 15957 Castaño-Rodríguez N. Goh K.L. Fock K.M. Mitchell H.M. Kaakoush N.O. Dysbiosis of the microbiome in gastric carcinogenesis Sci. Rep 2017 7 1595710.1038/s41598-017-16289-2569843229162924Search in Google Scholar

[40]Yang I., Woltemate S., Piazuelo M.B., Bravo L.E., Yepez M.C., Romero-Gallo J., Delgado A.G., Wilson K.T., Peek R.M., Correa P., et al.: Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia. Sci. Rep., 2016; 6: 18594 Yang I. Woltemate S. Piazuelo M.B. Bravo L.E. Yepez M.C. Romero-Gallo J. Delgado A.G. Wilson K.T. Peek R.M. Correa P. et al Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia Sci. Rep 2016 6 1859410.1038/srep18594470044626729566Search in Google Scholar

[41]Hsieh Y.Y., Tung S.Y., Pan H.Y., Yen C.W., Xu H.W., Lin Y.J., Deng Y.F., Hsu W.T., Wu C.S., Li C.: Increased abundance of Clostridium and Fusobacterium in gastric microbiota of patients with gastric cancer in Taiwan. Sci. Rep., 2018; 8: 158 Hsieh Y.Y. Tung S.Y. Pan H.Y. Yen C.W. Xu H.W. Lin Y.J. Deng Y.F. Hsu W.T. Wu C.S. Li C. Increased abundance of Clostridium and Fusobacterium in gastric microbiota of patients with gastric cancer in Taiwan Sci. Rep 2018 8 15810.1038/s41598-017-18596-0576054129317709Search in Google Scholar

[42]Coker O.O., Dai Z., Nie Y., Zhao G., Cao L., Nakatsu G., Wu W.K., Wong S.H., Chen Z., Sung J.J., Yu J.: Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut, 2018; 67: 1024-1032 Coker O.O. Dai Z. Nie Y. Zhao G. Cao L. Nakatsu G. Wu W.K. Wong S.H. Chen Z. Sung J.J. Yu J. Mucosal microbiome dysbiosis in gastric carcinogenesis Gut 2018 67 1024 103210.1136/gutjnl-2017-314281596934628765474Search in Google Scholar

[43]de Leeuw M.A., Duval M.X.: The presence of periodontal pathogens in gastric cancer. Explor. Res. Hypothesis Med., 2020; 5: 87-96 de Leeuw M.A. Duval M.X. The presence of periodontal pathogens in gastric cancer Explor. Res. Hypothesis Med 2020 5 87 9610.1101/2020.03.23.003426Search in Google Scholar

[44]Salazar C.R., Francois F., Li Y., Corby P., Hays R., Leung C., Bedi S., Segers S., Queiroz E., Sun J., et al.: Association between oral health and gastric precancerous lesions. Carcinogenesis, 2012; 33: 399-403 Salazar C.R. Francois F. Li Y. Corby P. Hays R. Leung C. Bedi S. Segers S. Queiroz E. Sun J. et al Association between oral health and gastric precancerous lesions Carcinogenesis 2012 33 399 40310.1093/carcin/bgr284338402422139442Search in Google Scholar

[45]Sun J.H., Li X.L., Yin J., Li Y.H., Hou B.X., Zhang Z.: A screening method for gastric cancer by oral microbiome detection. Oncol. Rep., 2018; 39: 2217-2224 Sun J.H. Li X.L. Yin J. Li Y.H. Hou B.X. Zhang Z. A screening method for gastric cancer by oral microbiome detection Oncol. Rep 2018 39 2217 222410.3892/or.2018.628629498406Search in Google Scholar

[46]Wu J., Xu S., Xiang C., Cao Q., Li Q., Huang J., Shi L., Zhang J., Zhan Z.: Tongue coating microbiota community and risk effect on gastric cancer. J. Cancer, 2018; 9: 4039-4048 Wu J. Xu S. Xiang C. Cao Q. Li Q. Huang J. Shi L. Zhang J. Zhan Z. Tongue coating microbiota community and risk effect on gastric cancer J. Cancer 2018 9 4039 404810.7150/jca.25280621877330410609Search in Google Scholar

[47]Eusebi L.H., Zagari R.M., Bazzoli F.: Epidemiology of Helicobacter pylori infection. Helicobacter, 2014; 19: 1-5 Eusebi L.H. Zagari R.M. Bazzoli F. Epidemiology of Helicobacter pylori infection Helicobacter 2014 19 1 510.1111/hel.1216525167938Search in Google Scholar

[48]Kuklińska U., Łasica A.M., Jagusztyn-Krynicka E.K.: Białko CagA Helicobacter pylori – pierwsza zidentyfikowana bakteryjna onkoproteina. Post. Mikrobiol., 2011; 50: 97-106 Kuklińska U. Łasica A.M. Jagusztyn-Krynicka E.K. Białko CagA Helicobacter pylori – pierwsza zidentyfikowana bakteryjna onkoproteina Post. Mikrobiol 2011 50 97 106Search in Google Scholar

[49]Mégraud F., Bessède E., Varon C.: Helicobacter pylori infection and gastric carcinoma. Clin. Microbiol. Infect., 2015; 21: 984-990 Mégraud F. Bessède E. Varon C. Helicobacter pylori infection and gastric carcinoma Clin. Microbiol. Infect 2015 21 984 99010.1016/j.cmi.2015.06.00426086571Search in Google Scholar

[50]Meng C., Bai C., Brown T.D., Hood L.E., Tian Q.: Human gut microbiota and gastrointestinal cancer. Genomics Proteomics Bio-informatics, 2018; 16: 33-49 Meng C. Bai C. Brown T.D. Hood L.E. Tian Q. Human gut microbiota and gastrointestinal cancer Genomics Proteomics Bio-informatics 2018 16 33 4910.1016/j.gpb.2017.06.002600025429474889Search in Google Scholar

[51]Cheung K.S., Leung W.K.: Long-term use of proton-pump inhibitors and risk of gastric cancer: A review of the current evidence. Therap. Adv. Gastroenterol., 2019; 12: 1756284819834511 Cheung K.S. Leung W.K. Long-term use of proton-pump inhibitors and risk of gastric cancer: A review of the current evidence Therap. Adv. Gastroenterol 2019 12 175628481983451110.1177/1756284819834511641548230886648Search in Google Scholar

[52]Correa P.: Human gastric carcinogenesis: A multistep and multi-factorial process – First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res., 1992; 52: 6735-6740 Correa P. Human gastric carcinogenesis: A multistep and multi-factorial process – First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention Cancer Res 1992 52 6735 6740Search in Google Scholar

[53]Zhao Y., Zhang J., Cheng A.S., Yu J., To K.F., Kang W.: Gastric cancer: Genome damaged by bugs. Oncogene, 2020; 39: 34273442 Zhao Y. Zhang J. Cheng A.S. Yu J. To K.F. Kang W. Gastric cancer: Genome damaged by bugs Oncogene 2020 39 3427344210.1038/s41388-020-1241-4717658332123313Search in Google Scholar

[54]Bień S.: Rola infekcji wirusem Epsteina i Barr w schorzeniach głowy i szyi. Pol. Przegl. Otorynolaryngol., 2013; 2: 127-136 Bień S. Rola infekcji wirusem Epsteina i Barr w schorzeniach głowy i szyi Pol. Przegl. Otorynolaryngol 2013 2 127 13610.1016/j.ppotor.2013.08.010Search in Google Scholar

[55]Bocian J., Januszkiewicz-Lewandowska D.: Zakażenia EBV – cykl życiowy, metody diagnostyki, chorobotwórczość. Postępy Hig. Med. Dośw., 2011; 65: 286-298 Bocian J. Januszkiewicz-Lewandowska D. Zakażenia EBV – cykl życiowy, metody diagnostyki, chorobotwórczość Postępy Hig. Med. Dośw 2011 65 286 29810.5604/17322693.943104Search in Google Scholar

[56]Żuk-Wasek A.: Charakterystyka białek wirusa Epsteina-Barr – ich udział w zakażeniu latentnym i powiązanie z procesami nowotworzenia. Post. Mikrobiol., 2012; 51: 191-201 Żuk-Wasek A. Charakterystyka białek wirusa Epsteina-Barr – ich udział w zakażeniu latentnym i powiązanie z procesami nowotworzenia Post. Mikrobiol 2012 51 191 201Search in Google Scholar

[57]Polakovicova I., Jerez S., Wichmann I.A., Sandoval-Bórquez A., Carrasco-Véliz N., Corvalán A.H.: Role of microRNAs and exosomes in Helicobacter pylori and Epstein-Barr virus associated gastric cancers. Front. Microbiol., 2018; 9: 63 Polakovicova I. Jerez S. Wichmann I.A. Sandoval-Bórquez A. Carrasco-Véliz N. Corvalán A.H. Role of microRNAs and exosomes in Helicobacter pylori and Epstein-Barr virus associated gastric cancers Front. Microbiol 2018 9 6310.3389/fmicb.2018.00636Search in Google Scholar

[58]Bruno G., Zaccari P., Rocco G., Scalese G., Panetta C., Porowska B., Pontone S., Severi C.: Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World J. Gastroenterol., 2019; 25: 2706-2719 Bruno G. Zaccari P. Rocco G. Scalese G. Panetta C. Porowska B. Pontone S. Severi C. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified World J. Gastroenterol 2019 25 2706 271910.3748/wjg.v25.i22.2706Search in Google Scholar

[59]Doorakkers E., Lagergren J., Engstrand L., Brusselaers N.: Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population. Gut, 2018; 67: 2092-2096 Doorakkers E. Lagergren J. Engstrand L. Brusselaers N. Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population Gut 2018 67 2092 209610.1136/gutjnl-2017-315363Search in Google Scholar

[60]Arora N., Majumer K., Gupta A.: Gastric cancer and the microbiome. Asian Pac. J. Trop. Dis., 2015; 5: 353-35 Arora N. Majumer K. Gupta A. Gastric cancer and the microbiome Asian Pac. J. Trop. Dis 2015 5 353 3510.1016/S2222-1808(14)60796-9Search in Google Scholar

[61]Wong B.C., Lam S.K., Wong W.M., Chen J.S., Zheng T.T., Feng R.E., Lai K.C., Hu W.H., Yuen S.T., Leung S.Y, et al.: Helicobacter pylori eradication to prevent gastric cancerin a high-risk region of China: A randomized controlled trial. JAMA, 2004, 291: 187-194 Wong B.C. Lam S.K. Wong W.M. Chen J.S. Zheng T.T. Feng R.E. Lai K.C. Hu W.H. Yuen S.T. Leung S.Y et al Helicobacter pylori eradication to prevent gastric cancerin a high-risk region of China: A randomized controlled trial JAMA 2004 291 187 19410.1001/jama.291.2.18714722144Search in Google Scholar

[62]Stauning A.T., Nordestgaard R.L.M., Frandsen T.H., Andersen L.P.: Gastric microbiota and resistance to antibiotics. In: Helicobacter Pylori - New Approaches of an Old Human Microorganism, eds.: B.M. Roesler. IntechOpen, London 2018 Stauning A.T. Nordestgaard R.L.M. Frandsen T.H. Andersen L.P. Gastric microbiota and resistance to antibiotics. In: Helicobacter Pylori - New Approaches of an Old Human Microorganism, eds.: B.M. Roesler. IntechOpen London 2018Search in Google Scholar

[63]Brusselaers N., Wahlin K., Engstrand L., Lagergren J.: Maintenance therapy with proton pump inhibitors and risk of gastric cancer: A nationwide population-based cohort study in Sweden. BMJ Open, 2017; 7: e017739 Brusselaers N. Wahlin K. Engstrand L. Lagergren J. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: A nationwide population-based cohort study in Sweden BMJ Open 2017 7 e01773910.1136/bmjopen-2017-017739566522629084798Search in Google Scholar

[64]Peng Y.C., Huang L.R., Lin C.L., Hsu W.Y., Chang C.S., Yeh H.Z., Kao C.H.: Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD. Gut, 2019; 68: 374376 Peng Y.C. Huang L.R. Lin C.L. Hsu W.Y. Chang C.S. Yeh H.Z. Kao C.H. Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD Gut 2019 68 37437610.1136/gutjnl-2018-31605729472295Search in Google Scholar

[65]Kim J.J.: Upper gastrointestinal cancer and reflux disease. J. Gastric Cancer, 2013; 13: 79-85 Kim J.J. Upper gastrointestinal cancer and reflux disease J. Gastric Cancer 2013 13 79 8510.5230/jgc.2013.13.2.79370513623844321Search in Google Scholar

[66]Parsons B.N., Ijaz U.Z., D’Amore R., Burkitt M.D., Eccles R., Lenzi L., Duckworth C.A., Moore A.R., Tiszlavicz L., Varro A., et al.: Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use. PLoS Pathog., 2017; 13: e1006653 Parsons B.N. Ijaz U.Z. D’Amore R. Burkitt M.D. Eccles R. Lenzi L. Duckworth C.A. Moore A.R. Tiszlavicz L. Varro A. et al Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use PLoS Pathog 2017 13 e100665310.1371/journal.ppat.1006653566773429095917Search in Google Scholar

[67]Shi Y.C., Cai S.T., Tian Y.P., Zhao H.J., Zhang Y.B., Chen J., Ren R.R., Luo X., Peng L.H., Sun G., Yang Y.S:. Effects of proton pump inhibitors on the gastrointestinal microbiota in gastroesophageal reflux disease. Genomics Proteomics Bioinformatics, 2019; 17: 52-63 Shi Y.C. Cai S.T. Tian Y.P. Zhao H.J. Zhang Y.B. Chen J. Ren R.R. Luo X. Peng L.H. Sun G. Yang Y.S Effects of proton pump inhibitors on the gastrointestinal microbiota in gastroesophageal reflux disease Genomics Proteomics Bioinformatics 2019 17 52 6310.1016/j.gpb.2018.12.004652091531028880Search in Google Scholar

[68]Zhang B., Ling T., Zhaxi P., Cao Y., Qian L., Zhao D., Kang W., Zhang W., Wang L., Xu G., Zou X.: Proton pump inhibitor pantoprazole inhibits gastric cancer metastasis via suppression of telomerase reverse transcriptase gene expression. Cancer Lett., 2019; 452: 23-30 Zhang B. Ling T. Zhaxi P. Cao Y. Qian L. Zhao D. Kang W. Zhang W. Wang L. Xu G. Zou X. Proton pump inhibitor pantoprazole inhibits gastric cancer metastasis via suppression of telomerase reverse transcriptase gene expression Cancer Lett 2019 452 23 3010.1016/j.canlet.2019.03.02930910586Search in Google Scholar